Change in Subfoveal Choroidal Thickness following Cataract Surgery Imaged with Enhanced Depth Imaging Optical Coherence Tomography
Klinische Monatsblätter für Augenheilkunde · 01.08.2023 · 240 (08) · 989-996
DOI: 10.1055/a-2120-7415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.08.2023. Verfasst von Lars H B Mackenbrock und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Ophthalmology, Cataract. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Due to its invasive nature, cataract surgery can lead to inflammatory processes in the posterior segment, which can result in prolonged recovery times, reduced functional outcomes, and late-onset complications. The aim of the current study was to identify wherever phacoemulsification parameters play a role in choroidal thickness change following cataract surgery.
Methods
This prospective single-center study enrolled 31 patients (31 eyes) scheduled to undergo routine cataract surgery. Patients with previous ocular surgeries, pathologies or general disorders affecting vision were excluded. Patients were examined preoperatively, as well as 1, 4, and 12 weeks after surgery. Corrected distance visual acuity (CDVA), intraocular pressure (IOP) as well as cumulative dissipated energy (CDE), ultrasound time (UT), and fluids used during surgery were recorded. Subfoveal choroidal thickness was measured manually by two masked independent experts using enhanced depth imaging (EDI) optical coherence tomography (OCT). Furthermore, cataract density was automatically calculated using a custom MATLAB script and an anterior segment OCT.
Results
Subfoveal choroidal thickness increased significantly (p < 0.001, Studentʼs paired sample t-test) and continuously during the 12-week-long follow-up period. Both the nuclear lens density and the improvement in CDVA correlated significantly with this increase (r = 0.413, p = 0.021 and r = 0.421, p = 0.018, respectively). Neither the CDE (r = 0.334, p = 0.071), the UT (r = 0.102, p = 0.629), the amount of fluid used (r = 0.237, p = 0.27) nor the decrease in IOP (r = − 0.197, p = 0.288) showed any significant correlation with the choroidal swelling.
Conclusion
Cataract surgery leads to an increase in subfoveal choroidal thickness. While no statistically significant correlation to the phacoemulsification parameters could be established, this might be because of a selection bias due to the technological constraints of the OCT. Nevertheless, the choroid might play a central role in early- and late-onset complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital Heidelberg, Heidelberg, Germany.
ORCID-Profile: Lars H B Mackenbrock, Isabella D Baur, Gerd U Auffarth, Ramin Khoramnia
Zitieren
APA
Mackenbrock, L. H. B., Weindler, J. N., Labuz, G., Baur, I. D., Auffarth, G. U., & Khoramnia, R. (2023). Change in Subfoveal Choroidal Thickness following Cataract Surgery Imaged with Enhanced Depth Imaging Optical Coherence Tomography. Klinische Monatsblätter für Augenheilkunde, 240(08), 989-996. https://doi.org/10.1055/a-2120-7415
Vancouver
Mackenbrock LHB, Weindler JN, Labuz G, Baur ID, Auffarth GU, Khoramnia R. Change in Subfoveal Choroidal Thickness following Cataract Surgery Imaged with Enhanced Depth Imaging Optical Coherence Tomography. Klinische Monatsblätter für Augenheilkunde. 2023;240(08):989-996. doi:10.1055/a-2120-7415
BibTeX
@article{Mackenbrock2023,
author = {Mackenbrock, Lars H B and Weindler, Jan N and Labuz, Grzegorz and Baur, Isabella D and Auffarth, Gerd U and Khoramnia, Ramin},
title = {Change in Subfoveal Choroidal Thickness following Cataract Surgery Imaged with Enhanced Depth Imaging Optical Coherence Tomography},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2023},
volume = {240},
number = {08},
pages = {989--996},
doi = {10.1055/a-2120-7415}
}
EUVIMED